Global PVA Drugs Market 2014-2018

グローバル・閉経後膣萎縮(PVA)治療薬市場動向(2014-2018)

◆タイトル:Global PVA Drugs Market 2014-2018
◆商品コード:IRTNTR3488
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年4月25日
◆ページ数:58
◆資料形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥308,000見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"グローバル・閉経後膣萎縮(PVA)治療薬市場動向(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、種類別分析、投与経路(ROA)別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About PVA Drugs
Vaginal atrophy is defined as decrease in estrogen production. Less estrogen leads to thinning, drying, and decreased elasticity of the vaginal tissues. PVA is defined as the decrease in estrogen after the menopause. Up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. In PVA there are symptoms of redness, burning, itching, dryness, irritation, and dyspareunia. HRT, estrogen creams, and other topical preparations are used in the treatment of PVA.
TechNavio’s analysts forecast the Global PVA Drugs market will grow at a CAGR of 7.1 percent over the period 2013-2018.
Covered in this Report
The Global PVA Drugs market can be divided into two segments: Topical Estrogen and Systemic Estrogen. To calculate the market size, the report considers the revenue generated from the sales of various drugs (creams, tablets, and rings) used in the treatment of PVA.
TechNavio’s report, the Global PVA Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global PVA Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Actavis plc
• Novo Nordisk A/S
• Pfizer Inc.
• Shionogi & Co. Ltd.
Other Prominent Vendors

• ANI Pharmaceuticals Inc.
• Bionovo Inc.
• EndoCeutics Inc.
• QuatRx Pharmaceutical Co.
• PeP-Tonic Medical AB
• Teva Pharmaceutical Industries Ltd.
• Therapeutics MD Inc.
• Upsher-Smith Laboratories Inc.
Market Driver
• Significant Unmet Need.
• For a full, detailed list, view our report.
Market Challenge
• Increasing Number of Patent Expirations.
• For a full, detailed list, view our report.
Market Trend
• Increase in Awareness of PVA.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.1.1 Product Offerings
Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 PVA Drugs Market in the US
06.3.1 Market Size and Forecast
06.4 PVA Drugs Market in Europe
06.4.1 Market Size and Forecast
06.5 Five Forces Analysis
07. Competitive Analysis of Marketed Products
08. Pipeline Snapshot
09. Rate of Incidence and Prevalence
10. Market Segmentation by Types
10.1 Topical Estrogen
10.1.1 Vaginal Cream
10.1.2 Vaginal Tablet
10.1.3 Vaginal Ring
10.2 Systemic Estrogen
10.2.1 Oral Estradiol
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Pfizer Inc.
20.1.1 Business Overview
20.1.2 Business Segmentation
20.1.3 Key Information
20.1.4 SWOT Analysis
20.2 Shionogi & Co. Ltd.
20.2.1 Business Overview
20.2.2 Key Information
20.2.3 SWOT Analysis
20.3 Novo Nordisk A/S
20.3.1 Business Overview
20.3.2 Business Segmentation
20.3.3 Key Information
20.3.4 SWOT Analysis
20.4 Actavis plc
20.4.1 Business Overview
20.4.2 Business Segmentation
20.4.3 Key Information
20.4.4 SWOT Analysis
21. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global PVA Drugs Market 2013-2018 (US$ billion)
Exhibit 3: PVA Drugs Market in the US 2013-2018 (US$ billion)
Exhibit 4: PVA Drugs Market in Europe 2013-2018 (US$ billion)
Exhibit 5: Global PVA Drugs Market Segmentation by Route of Administration
Exhibit 6: Global PVA Drugs Market by Geographical Segmentation 2013
Exhibit 7: Business Segmentation of Pfizer Inc.
Exhibit 8: Business Segmentation of Novo Nordisk A/S
Exhibit 9: Business Segmentation of Actavis plc



【掲載企業】

Actavis plc, Novo Nordisk A/S, Pfizer Inc., Shionogi & Co. Ltd., ANI Pharmaceuticals Inc., Bionovo Inc., EndoCeutics Inc., QuatRx Pharmaceutical Co., PeP-Tonic Medical AB, Teva Pharmaceutical Industries Ltd., Therapeutics MD Inc., Upsher-Smith Laboratories Inc.

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[グローバル・閉経後膣萎縮(PVA)治療薬市場動向(2014-2018)] (Global PVA Drugs Market 2014-2018 / IRTNTR3488)販売に関する免責事項
[グローバル・閉経後膣萎縮(PVA)治療薬市場動向(2014-2018)] (Global PVA Drugs Market 2014-2018 / IRTNTR3488)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆